Clinical characteristics and the role of IL-6 in acute-on-chronic liver failure patients with or without COVID-19: a multicenter paired cohort study
ACLF patients with COVID-19 have increased risk for thrombocytopenia, more obvious inflammatory response, and rapid disease progression 1 week after admission, but the 28-day mortality rate is similar to that of ACLF patients without COVID-19.
Authors
- Wenrui Zhang (ORCID: https://orcid.org/0000-0001-7059-3866)
- Jia Yao (ORCID: https://orcid.org/0000-0003-2210-7717)
- Ruoyu Yao (ORCID: https://orcid.org/0000-0001-5999-575X)
- Han Wang (ORCID: https://orcid.org/0000-0001-5968-2171)
- Xiujuan Fu (ORCID: https://orcid.org/0000-0003-2723-8169)
- G.Z. Xu
- Yu Chen (ORCID: https://orcid.org/0000-0003-3610-594X)
Institutions
- Shanxi Medical University (CN)
- Capital Medical University (CN)
- Beijing YouAn Hospital (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3389/fcimb.2024.1471974
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00